UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 741

Sortiert nach

A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B

Gastroenterology (New York, N.Y. 1943), 2005-08, Vol.129 (2), p.528-536

2005

Link zum Volltext

Verfügbarkeit prüfen

A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis B

Gastroenterology (New York, N.Y. 1943), 2005-08, Vol.129 (2), p.528-536

2005

Link zum Volltext

Verfügbarkeit prüfen

17 - Renal Failure in Cirrhosis

Zakim and Boyer's Hepatology, 2018, p.262-280.e5

Wong, Florence

Seventh Edition, 2018

Link zum Volltext

Verfügbarkeit prüfen

219 Results of a one-year international phase IIB comparative trial of telbivudine, lamivudine, and the combination, in patients with chronic hepatitis B

Hepatology (Baltimore, Md.), 2003, Vol.38, p.262-262

2003

Link zum Volltext

Verfügbarkeit prüfen

256: PRIOR PERIODONITIS AND PATIENT-REPORTED OUTCOMES PREDICT THE RISK OF 3-MONTH HOSPITALIZATION IN A MULTI-CENTER CIRRHOSIS COHORT

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-54-S-54

2022

Link zum Volltext

Verfügbarkeit prüfen

3-Aminocarbonylpyridinium difluoroacetate at 123 #8197;K

Acta crystallographica. Section E, Structure reports online, 2009-11, Vol.65 (11), p.o2896-o2897

2009

Link zum Volltext

Verfügbarkeit prüfen

3-Aminocarbonylpyridinium difluoroacetate at 123 K

Acta crystallographica. Section E, Structure reports online, 2009-11, Vol.65 (11), p.o2896-o2897

2009

Link zum Volltext

Verfügbarkeit prüfen

The 3‐month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis

Hepatology (Baltimore, Md.), 2016-07, Vol.64 (1), p.200-208

2016

Link zum Volltext

Verfügbarkeit prüfen

421 - Nacseld Acute-on-Chronic Liver Failure (NACSELD-ACLF) Predicts 30-Day Mortality in Admitted Cirrhotic Patients

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S1056-S1057

2017

Link zum Volltext

Verfügbarkeit prüfen

431 SPECIFIC URINARY AND SERUM METABOLITES ON ADMISSION PREDICT THE DEVELOPMENT OF AKI AND NEED FOR DIALYSIS IN HOSPITALIZED PATIENTS WITH CIRRHOSIS

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-775-S-776

2021

Link zum Volltext

Verfügbarkeit prüfen

458 ARTIFICIAL INTELLIGENCE TECHNIQUES DEMONSTRATE BETTER PREDICTION FOR 90-DAY READMISSION AND DEATH IN WOMEN THAN MEN WITH CIRRHOSIS

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-1279-S-1279

2020

Link zum Volltext

Verfügbarkeit prüfen

499 - Primary SBP Prophylaxis is Associated with Higher ICU Admission and 30-Day Mortality Compared to Secondary SBP Prophylaxis

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-1091-S-1091

2018

Link zum Volltext

Verfügbarkeit prüfen

543 In-Hospital Mortality in Cirrhosis is Related to Nosocomial Infections Independent of MELD Score:the North American Consortium for the Study of End-Stage Liver Disease (Nacseld) Study

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-918-S-918

2012

Link zum Volltext

Verfügbarkeit prüfen

573 – Predictive Factors for the Development of Acute-Onchronic Liver Failure in a North American Cohort of Hospitalized Cirrhotic Patients with Decompensation

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-1205-S-1205

2019

Link zum Volltext

Verfügbarkeit prüfen

575 The 3-Month Readmission Rate Remains Unacceptably High in a Large Multi-Center Cohort of Cirrhotic Patients

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-982-S-983

2015

Link zum Volltext

Verfügbarkeit prüfen

591 Validation of Infection-Related Acute-on-Chronic Liver Failure (I-ACLF) Definition for 30-Day Mortality Prediction in Infected and Uninfected Hospitalized Cirrhotic Patients

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-988-S-988

2015

Link zum Volltext

Verfügbarkeit prüfen

The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study

Muscle & nerve, 2013-09, Vol.48 (3), p.357-368

2013

Link zum Volltext

Verfügbarkeit prüfen

THE 6-minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study

Muscle & nerve, 2013-09, Vol.48 (3), p.343-356

2013

Link zum Volltext

Verfügbarkeit prüfen

652 ALBUMIN USE AND AKI ARE INDEPENDENTLY ASSOCIATED WITH RESPIRATORY DISTRESS DEVELOPMENT IN A MULTI-CENTER COHORT OF INPATIENTS WITH CIRRHOSIS

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-1257-S-1257

2023

Link zum Volltext

Verfügbarkeit prüfen

82: SERUM METABOLITES ON ADMISSION ASSOCIATE WITH OCCURRENCE OF NOSOCOMIAL INFECTIONS IN HOSPITALIZED PATIENTS WITH CIRRHOSIS

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1114-S-1114

2022

Link zum Volltext

Verfügbarkeit prüfen

AASLD Practice Guidance on Acute-on-chronic liver failure and the management of critically ill patients with cirrhosis

Hepatology (Baltimore, Md.), 2024-06, Vol.79 (6), p.1463-1502

2024

Link zum Volltext

Verfügbarkeit prüfen

Abstract 168: Feasibility and Safety of Thrombolysis by Telestroke Through Off-site Mobile Teleconsultation With iPad

Stroke (1970), 2016-02, Vol.47 (suppl_1)

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 578: RARRES1 is a tumor suppressor in triple-negative breast cancer cell lines

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.578-578

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 86: Morphological Evolution of Symptomatic Intracranial Atherosclerotic Plaques: a 10-year Longitudinal Study by 3-Dimensional Rotational Angiography

Stroke (1970), 2018-01, Vol.49 (Suppl_1)

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-12-09: Randomized study to determine the efficacy of Olanzapine for the prevention of chemotherapy-induced nausea and vomiting (CINV) in Chinese breast cancer patients (PTS)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P2-P2-12-09

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 741

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(685)
Mit Volltextzugriff
(635)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(411)
Life Sciences & Biomedicine
(370)
Humans
(350)
Male
(181)
Female
(172)
Gastroenterology & Hepatology
(161)
Middle Aged
(152)
Aged
(107)
Liver Cirrhosis - Complications
(85)
Adult
(81)
Biological And Medical Sciences
(78)
Medical Sciences
(71)
Cirrhosis
(62)
Prospective Studies
(49)
Treatment Outcome
(49)
Ascites
(43)
Patients
(40)
Gastroenterology. Liver. Pancreas. Abdomen
(39)
Liver Cirrhosis
(38)
Liver Diseases
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Hepatology
(74)
Gastroenterology
(67)
Journal Of Hepatology
(38)
The American Journal Of Gastroenterology
(26)
Liver Transplantation
(22)
Clinical Gastroenterology And Hepatology
(17)
Gut
(13)
Journal Of Clinical Oncology
(11)
Stroke
(9)
Liver International
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B

A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis B

17 - Renal Failure in Cirrhosis

219 Results of a one-year international phase IIB comparative trial of telbivudine, lamivudine, and the combination, in patients with chronic hepatitis B

256: PRIOR PERIODONITIS AND PATIENT-REPORTED OUTCOMES PREDICT THE RISK OF 3-MONTH HOSPITALIZATION IN A MULTI-CENTER CIRRHOSIS COHORT

3-Aminocarbonylpyridinium difluoroacetate at 123 #8197;K

3-Aminocarbonylpyridinium difluoroacetate at 123 K

The 3‐month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis

421 - Nacseld Acute-on-Chronic Liver Failure (NACSELD-ACLF) Predicts 30-Day Mortality in Admitted Cirrhotic Patients

431 SPECIFIC URINARY AND SERUM METABOLITES ON ADMISSION PREDICT THE DEVELOPMENT OF AKI AND NEED FOR DIALYSIS IN HOSPITALIZED PATIENTS WITH CIRRHOSIS

458 ARTIFICIAL INTELLIGENCE TECHNIQUES DEMONSTRATE BETTER PREDICTION FOR 90-DAY READMISSION AND DEATH IN WOMEN THAN MEN WITH CIRRHOSIS

499 - Primary SBP Prophylaxis is Associated with Higher ICU Admission and 30-Day Mortality Compared to Secondary SBP Prophylaxis

543 In-Hospital Mortality in Cirrhosis is Related to Nosocomial Infections Independent of MELD Score:the North American Consortium for the Study of End-Stage Liver Disease (Nacseld) Study

573 – Predictive Factors for the Development of Acute-Onchronic Liver Failure in a North American Cohort of Hospitalized Cirrhotic Patients with Decompensation

575 The 3-Month Readmission Rate Remains Unacceptably High in a Large Multi-Center Cohort of Cirrhotic Patients

591 Validation of Infection-Related Acute-on-Chronic Liver Failure (I-ACLF) Definition for 30-Day Mortality Prediction in Infected and Uninfected Hospitalized Cirrhotic Patients

The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study

THE 6-minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study

652 ALBUMIN USE AND AKI ARE INDEPENDENTLY ASSOCIATED WITH RESPIRATORY DISTRESS DEVELOPMENT IN A MULTI-CENTER COHORT OF INPATIENTS WITH CIRRHOSIS

82: SERUM METABOLITES ON ADMISSION ASSOCIATE WITH OCCURRENCE OF NOSOCOMIAL INFECTIONS IN HOSPITALIZED PATIENTS WITH CIRRHOSIS

AASLD Practice Guidance on Acute-on-chronic liver failure and the management of critically ill patients with cirrhosis

Abstract 168: Feasibility and Safety of Thrombolysis by Telestroke Through Off-site Mobile Teleconsultation With iPad

Abstract 578: RARRES1 is a tumor suppressor in triple-negative breast cancer cell lines

Abstract 86: Morphological Evolution of Symptomatic Intracranial Atherosclerotic Plaques: a 10-year Longitudinal Study by 3-Dimensional Rotational Angiography

Abstract P2-12-09: Randomized study to determine the efficacy of Olanzapine for the prevention of chemotherapy-induced nausea and vomiting (CINV) in Chinese breast cancer patients (PTS)

Suchergebnisse filtern